We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Otorhinolaryngology

Otorhinolaryngology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

A Post-Tonsillectomy Hemorrhage Guideline With Nebulized Tranexamic Acid Was Linked to Fewer Returns to the Operating Room
Emergency Medicineclinical care guidelineemergency department

A Post-Tonsillectomy Hemorrhage Guideline With Nebulized Tranexamic Acid Was Linked to Fewer Returns to the Operating Room

By MedXY|Jun 1, 2026

A quality-improvement guideline standardizing nebulized tranexamic acid for post-tonsillectomy hemorrhage achieved high protocol adherence and was associated with a marked reduction in operative hemorrhage control.

Frenotomy Use in Danish Infants More Than Doubled Over a Decade, With Marked Geographic Variation and Limited Signals of Serious Harm
newsankyloglossiafrenotomy

Frenotomy Use in Danish Infants More Than Doubled Over a Decade, With Marked Geographic Variation and Limited Signals of Serious Harm

By MedXY|May 29, 2026

A nationwide Danish cohort study found rapid growth in infant frenotomy, wide municipal variation, and rare severe complications, raising questions about clinical appropriateness in the setting of limited evidence for benefit.

Nebulized Ciprofloxacin-Dexamethasone Appears Well Tolerated After Pediatric Airway Surgery in a Large Retrospective Cohort
newsciprofloxacin-dexamethasonepediatric airway surgery

Nebulized Ciprofloxacin-Dexamethasone Appears Well Tolerated After Pediatric Airway Surgery in a Large Retrospective Cohort

By MedXY|May 29, 2026

A single-center retrospective study of 399 pediatric airway surgery patients found no significant adverse events clearly linked to postoperative nebulized ciprofloxacin-dexamethasone, supporting short-term safety while leaving efficacy and

Volumetric Thresholds After Glossectomy May Predict Feeding Tube Dependence and Poor Speech
newsflap reconstructionglossectomy

Volumetric Thresholds After Glossectomy May Predict Feeding Tube Dependence and Poor Speech

By MedXY|May 27, 2026

A retrospective cohort study suggests that preoperative tumor burden, extent of tongue resection, and degree of volume restoration are strongly associated with swallowing and speech outcomes after glossectomy.

Anti-EBV BNLF2b Antibody Shows High Accuracy for Outpatient Diagnosis of Suspected Nasopharyngeal Carcinoma
newsBNLF2bdiagnostic biomarker

Anti-EBV BNLF2b Antibody Shows High Accuracy for Outpatient Diagnosis of Suspected Nasopharyngeal Carcinoma

By MedXY|May 25, 2026

In a prospective multicenter cohort, P85-Ab achieved 93.0% sensitivity and 97.3% specificity for suspected nasopharyngeal carcinoma, outperforming conventional EBV serologies in outpatient practice.

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma
Hematology-Oncologybiomarkernasopharyngeal carcinoma

Diagnostic Performance of Anti-Epstein-Barr Virus BNLF2b in Suspected Nasopharyngeal Carcinoma

By MedXY|May 25, 2026

P85-Ab, an anti-EBV BNLF2b antibody test, showed excellent accuracy for suspected nasopharyngeal carcinoma and outperformed older EBV markers in most outpatient settings.

Earlier Cricopharyngeal Intervention May Improve Oral Intake in Absent UES Opening After Neurological Injury
NeurologycricopharyngeusDysphagia

Earlier Cricopharyngeal Intervention May Improve Oral Intake in Absent UES Opening After Neurological Injury

By MedXY|May 20, 2026

A small retrospective series suggests that cricopharyngeus-targeted procedures can improve upper esophageal sphincter opening and oral intake after neurological injury, but aspiration risk often persists and ongoing swallowing therapy remai

Fatigue After Thyroidectomy: What Patients Actually Experience
General Surgeryfatiguepatient experience

Fatigue After Thyroidectomy: What Patients Actually Experience

By MedXY|May 20, 2026

A qualitative study found that fatigue after thyroidectomy is common, disruptive, and often unexpected. Patients described major impacts on work and daily life, and many wanted surgeons to warn them about it before surgery.

Identifying High-Risk Children Safe for Same-Day Discharge After Tonsillectomy
newsobesityPediatrics

Identifying High-Risk Children Safe for Same-Day Discharge After Tonsillectomy

By MedXY|May 18, 2026

Children with obesity and severe OSA usually stay overnight after tonsillectomy, but this study found most had no major complications. Oxygen nadir and AHI may help identify very low-risk patients who could be considered for same-day discha

Systematic V2 Vagal Stimulation Improves Detection of Post-Thyroidectomy Vocal Cord Dysfunction and May Better Guide Staged Surgery
General Surgeryintraoperative neuromonitoringrecurrent laryngeal nerve

Systematic V2 Vagal Stimulation Improves Detection of Post-Thyroidectomy Vocal Cord Dysfunction and May Better Guide Staged Surgery

By MedXY|May 13, 2026

A 2026 cross-sectional study suggests that routine postdissection vagal stimulation during thyroidectomy detects recurrent laryngeal nerve dysfunction more sensitively than RLN stimulation alone and may reduce the risk of bilateral vocal co

A CBT-Based Mobile App Significantly Reduced Tinnitus Distress in a Sham-Controlled Randomized Trial
newsCognitive Behavioral Therapydigital therapeutic

A CBT-Based Mobile App Significantly Reduced Tinnitus Distress in a Sham-Controlled Randomized Trial

By MedXY|May 11, 2026

In a 60-patient randomized trial, a digital therapeutic app delivering tinnitus education and CBT elements produced large, durable reductions in tinnitus-related distress over 16 weeks, with no serious safety concerns.

3D-Printed Temporal Bones Provide a Reliable, Objective Way to Assess Mastoidectomy Skill Across Otolaryngology Training
newscompetency-based trainingmastoidectomy

3D-Printed Temporal Bones Provide a Reliable, Objective Way to Assess Mastoidectomy Skill Across Otolaryngology Training

By MedXY|May 11, 2026

A prospective single-center study found that final product analysis on 3D-printed temporal bones reliably distinguished mastoidectomy performance by residency level and may support competency-based assessment.

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma
newscancer treatmentchemoradiotherapy

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma

By MedXY|May 8, 2026

A cohort study demonstrates that reduced-dose 60-Gy chemoradiotherapy effectively maintains locoregional control in HPV-positive oropharyngeal cancer patients while minimizing treatment toxicity, with 5-year survival rates exceeding 92%.

Impact of Immunocompromise on Survival in HPV-Positive Throat Cancer Patients
newsHPVoropharyngeal cancer

Impact of Immunocompromise on Survival in HPV-Positive Throat Cancer Patients

By MedXY|May 8, 2026

This study examines how pre-existing immunocompromise affects survival and outcomes in patients with HPV-positive oropharyngeal cancer treated surgically. Immunocompromised patients showed significantly worse overall survival compared to no

Ergonomic Strain Is Common in Otolaryngology Surgery, With Pain Rising as Cases Become More Difficult and Prolonged
newsergonomicsmusculoskeletal pain

Ergonomic Strain Is Common in Otolaryngology Surgery, With Pain Rising as Cases Become More Difficult and Prolonged

By MedXY|May 4, 2026

A prospective study found frequent medium-to-high ergonomic risk and measurable postoperative pain among otolaryngology surgeons, highlighting modifiable occupational hazards in routine head and neck surgery.

Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Head and Neck Cancer
newshead and neck cancerimmunotherapy

Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Head and Neck Cancer

By MedXY|Apr 27, 2026

A large claims-based study reveals pembrolizumab dominates immunotherapy prescribing for head and neck cancer, with minimal usage growth since FDA approval. Immune-related adverse events occurred in 41.2% of patients, linked to specific com

Radiation-Induced OME: Bacterial Colonization Elevates Early Recurrence Risk Yet Lacks Long-Term Prognostic Value
newsBacterial colonizationnasopharyngeal carcinoma

Radiation-Induced OME: Bacterial Colonization Elevates Early Recurrence Risk Yet Lacks Long-Term Prognostic Value

By MedXY|Apr 27, 2026

Radiation-induced otitis media with effusion (RI-OME) shows heightened bacterial colonization with opportunistic pathogens. Although microbial presence predicts early recurrence (≤4 weeks post-tympanocentesis), it does not independently inf

Post-Thyroidectomy Calcium Strategies: Routine vs. PTH-Guided Supplementation Show Similar Efficacy
General Surgerycalcium supplementationHormon tuyến cận giáp

Post-Thyroidectomy Calcium Strategies: Routine vs. PTH-Guided Supplementation Show Similar Efficacy

By MedXY|Apr 23, 2026

A randomized trial comparing routine calcium supplementation with PTH-guided selective supplementation found no significant difference in preventing post-thyroidectomy hypocalcemia, offering flexibility in clinical practice.

RAI Outperforms mFI-5 in Predicting Post-UPPP Complications: A Frailty Stratification Breakthrough
Anesthesiologyfrailty assessmentrisk stratification

RAI Outperforms mFI-5 in Predicting Post-UPPP Complications: A Frailty Stratification Breakthrough

By MedXY|Apr 23, 2026

The Risk Analysis Index (RAI) significantly outperforms the modified frailty index-5 (mFI-5) in predicting mortality and major complications after uvulopalatopharyngoplasty, supporting its adoption for preoperative risk assessment in sleep

Amivantamab Falls Short of Tumor Shrinkage in Recurrent or Metastatic Adenoid Cystic Carcinoma, but Disease Stabilization Was Common
Hematology-OncologyamivantamabEGFR MET

Amivantamab Falls Short of Tumor Shrinkage in Recurrent or Metastatic Adenoid Cystic Carcinoma, but Disease Stabilization Was Common

By MedXY|Apr 20, 2026

In a phase 2 trial, amivantamab did not meet its primary response endpoint in recurrent/metastatic adenoid cystic carcinoma, but most patients achieved stable disease and toxicity was generally manageable.

Prev
7 / 13
1…56789…13
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles